Dane K. Wukich, MD, Receives the American Diabetes Association’s 2017 Roger Pecoraro Award


Michelle Kirkwood

May 19, 2017

Dane K. Wukich, MD, has been selected to receive the American Diabetes Association® (Association) 2017 Roger Pecoraro Award. This award recognizes a researcher who has made significant scientific contributions and demonstrates an untiring commitment to improving the understanding of the detection, treatment and prevention of diabetic foot complications. Dr. Wukich will be recognized with this honor during the Association’s 77th Scientific Sessions, June 9-13, 2017, at the San Diego Convention Center, and he will deliver the Roger Pecoraro Award Lecture, “Assessing Quality of Life in Patients with Diabetic Foot Disease: Why Does it Matter?,” on Saturday, June 10. 

Dr. Wukich is a professor and Dr. Charles F. Gregory Distinguished Chair of the Department of Orthopaedic Surgery at the University of Texas Southwestern Medical Center in Dallas. Previously, he established and directed the University of Pittsburgh Medical Center’s Mercy Center for Healing and Amputation Prevention. He has helped to train more than 150 resident physicians and 10 reconstructive foot and ankle fellows.

Also a United States Army veteran who served as a chief of orthopaedic surgery in the Army Medical Corps during Operations Desert Storm and Desert Shield, Dr. Wukich is internationally recognized for his work in limb salvage, management of diabetes-related complications and education.

“Thank you, Dr. Wukich, for your service to our nation in the Army Medical Corps and to medicine and science, and your continued commitment to improving outcomes for people with diabetes,” said the Association’s President of Medicine and Science Alvin C. Powers, MD. “Your leadership and work to prevent, manage and minimize diabetes-related loss-of-limbs has touched many lives. Congratulations on this award.”

Among his research contributions, Dr. Wukich has investigated foot and ankle problems in patients with traumatic brain injury or stroke, athletes and people with diabetes. With more than 100 publications and invited lectures delivered around the world, he is noted for leadership roles, excellence in teaching and compassionate quality care. He is actively involved in educating orthopaedic surgeons and has held leadership roles in the American Diabetes Association’s Foot Care Council and the Membership Committee of the American Academy of Orthopaedic Surgeons.

The American Diabetes Association’s 77th Scientific Sessions, to be held June 9-13, 2017, at the San Diego Convention Center, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, health care professionals have exclusive access to more than 2,500 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight interest areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Brenda Montgomery, RN, MSHS, CDE, President of Health Care and Education¹, will deliver her address on Saturday, June 10, and Alvin C. Powers, MD, President of Medicine and Science, will present his address on Sunday, June 11. Eight abstracts were selected by the Scientific Sessions Meeting Planning Committee to be presented on Tuesday, June 13, in the President’s Oral Session. These abstracts represent important research being conducted in the field of diabetes today. In total, the 2017 Scientific Sessions includes 378 abstracts in 49 oral sessions; 2,152 poster presentations including 50 moderated poster discussions; and 360 published-only abstracts.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)

1 Disclosures for Brenda Montgomery. Employer: AstraZeneca Pharmaceuticals. Montgomery's role as President, Health Care & Education of the American Diabetes Association (Association) is a voluntary position to which she was elected by the members of the Association in 2015. She continues to recuse herself from any and all discussions, decisions or votes that have or could be perceived as having a conflict of interest with her employer.